Asep Medical Holdings Inc
SEPSF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $75 | $74 | $74 | $21 |
| % Growth | 1.1% | 0% | 250% | – |
| Cost of Goods Sold | $34 | $39 | $327 | $76 |
| Gross Profit | $41 | $35 | -$253 | -$55 |
| % Margin | 54.9% | 46.8% | -342.3% | -259.1% |
| R&D Expenses | $1 | $45 | -$12 | $81 |
| G&A Expenses | $366 | $854 | $518 | $992 |
| SG&A Expenses | $366 | $854 | $675 | $1,489 |
| Sales & Mktg Exp. | $0 | $0 | $157 | $497 |
| Other Operating Expenses | $560 | $454 | $0 | $0 |
| Operating Expenses | $927 | $1,353 | $664 | $1,570 |
| Operating Income | -$886 | -$1,318 | -$917 | -$1,876 |
| % Margin | -1,184.2% | -1,781.5% | -1,239.2% | -8,873.3% |
| Other Income/Exp. Net | -$78 | -$17 | -$17 | -$402 |
| Pre-Tax Income | -$963 | -$1,335 | -$919 | -$2,278 |
| Tax Expense | $0 | $0 | -$157 | $0 |
| Net Income | -$733 | -$1,122 | -$762 | -$2,018 |
| % Margin | -980.4% | -1,516.8% | -1,029.9% | -9,543.8% |
| EPS | -0.01 | -0.015 | -0.01 | -0.027 |
| % Growth | 34.7% | -44.1% | 62.5% | – |
| EPS Diluted | -0.01 | -0.015 | -0.01 | -0.027 |
| Weighted Avg Shares Out | 76,126 | 76,126 | 74,692 | 74,184 |
| Weighted Avg Shares Out Dil | 76,126 | 76,126 | 74,692 | 74,184 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $24 |
| Interest Expense | $1 | $1 | $1 | $0 |
| Depreciation & Amortization | $326 | $327 | $327 | $327 |
| EBITDA | -$637 | -$1,008 | -$606 | -$1,975 |
| % Margin | -851.5% | -1,361.7% | -818.5% | -9,341.1% |